Nuytens Frederiek, D'Hondt Mathieu
a Department of Digestive and Hepatobiliary/Pancreatic Surgery , AZ Groeninge Hospital , Kortrijk , Belgium.
Acta Chir Belg. 2018 Aug;118(4):246-249. doi: 10.1080/00015458.2017.1321267. Epub 2017 May 3.
In the last few decades, sacral neurostimulation (SNS) has proven to be an effective treatment option for functional bowel disorders. Experience concerning the role of SNS in the treatment of chronic constipation due to neurogenic bowel dysfunction (NBD) however is limited.
In this report, we present the case of a 44-year old patient, with chronic refractory neurogenic constipation after a spontaneous cerebral hemorrhage, who was treated with SNS.
Prior to treatment with SNS, the Constipation Scoring System showed a score of 22/30. Three months after SNS implantation, this score was reduced to 5/30. Patient had successful evacuation of stool every one to two days. Medication could be reduced to 15 drops of picosulphate per day. Patient experienced a significant improvement in quality of life.
We believe that SNS could offer a safe, effective and relatively cost-effective treatment for patients with NBD refractory to conservative treatment.
在过去几十年中，骶神经刺激（SNS）已被证明是治疗功能性肠病的一种有效治疗选择。然而，关于SNS在治疗神经源性肠功能障碍（NBD）所致慢性便秘中的作用的经验有限。
在本报告中，我们介绍了一名44岁患者的病例，该患者在自发性脑出血后患有慢性难治性神经源性便秘，接受了SNS治疗。
在接受SNS治疗前，便秘评分系统显示得分为22/30。SNS植入三个月后，该评分降至5/30。患者每1至2天成功排便一次。药物用量可减至每天15滴比沙可啶。患者的生活质量有显著改善。
我们认为，SNS可为保守治疗难治的NBD患者提供一种安全、有效且相对经济高效的治疗方法。
